TOBRAMYCIN AND DEXAMETHASONE

TOBRAMYCIN AND DEXAMETHASONE was reported 3325 times

TOBRAMYCIN AND DEXAMETHASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIPOGRANULOMA 7 0.5385
1 AQUEOUS FIBRIN 20 0.3922
2 UVEITIS-GLAUCOMA-HYPHAEMA SYNDROME 5 0.2000
3 EMBOLIC PNEUMONIA 4 0.1905
4 CORNEAL EPITHELIOPATHY 6 0.1579
5 AQUEOUS HUMOUR LEAKAGE 3 0.1250
6 AMNIOTIC MEMBRANE GRAFT 3 0.1154
7 CONJUNCTIVAL DEFECT 3 0.1154
8 CONJUNCTIVAL BLEB 5 0.0926
9 ABSCESS OF EYELID 5 0.0893
10 CONJUNCTIVAL SCAR 12 0.0795
11 CILIARY HYPERAEMIA 7 0.0737
12 KERATITIS VIRAL 3 0.0732
13 OCULAR PEMPHIGOID 9 0.0720
14 CORNEAL EXFOLIATION 7 0.0686
15 DEAFNESS PERMANENT 11 0.0561
16 EYE INFECTION INTRAOCULAR 4 0.0513
17 HYPOPHARYNGEAL CANCER 4 0.0476
18 ANTERIOR CHAMBER FIBRIN 6 0.0465
19 HEPATIC CANDIDIASIS 3 0.0441
20 HYPOPYON 32 0.0386
21 CORNEAL IRRITATION 3 0.0375
22 TOXIC ANTERIOR SEGMENT SYNDROME 40 0.0367
23 ANTERIOR CHAMBER FLARE 8 0.0343
24 KERATITIS FUNGAL 7 0.0337
25 FLAT ANTERIOR CHAMBER OF EYE 6 0.0335
26 CORNEAL EPITHELIUM DEFECT 18 0.0310
27 OCULAR HYPERTENSION 55 0.0283
28 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 10 0.0275
29 CORNEAL INFILTRATES 8 0.0255
30 KERATIC PRECIPITATES 12 0.0253
31 KERATITIS BACTERIAL 4 0.0245
32 CORNEAL OPACITY 33 0.0242
33 CORNEAL THINNING 6 0.0233
34 EYELID CYST 6 0.0232
35 LENTICULAR OPACITIES 10 0.0229
36 CORNEAL DEFECT 3 0.0227
37 CENTRAL VISION LOSS 5 0.0224
38 IRIS ADHESIONS 11 0.0214
39 CATARACT CORTICAL 3 0.0201
40 CORNEAL OEDEMA 43 0.0192
41 HYPOTONY OF EYE 8 0.0190
42 VITRITIS 35 0.0189
43 CORNEAL EROSION 10 0.0186
44 CONJUNCTIVAL HYPERAEMIA 66 0.0185
45 CORNEAL INFECTION 4 0.0184
46 XEROPHTHALMIA 10 0.0170
47 VISUAL ACUITY REDUCED TRANSIENTLY 5 0.0162
48 CORNEAL PERFORATION 10 0.0158
49 EYE INFECTION VIRAL 5 0.0156
50 SYMBLEPHARON 4 0.0153
51 PUNCTATE KERATITIS 14 0.0153
52 ANTERIOR CHAMBER INFLAMMATION 9 0.0151
53 POSTERIOR CAPSULE OPACIFICATION 5 0.0146
54 EPIRETINAL MEMBRANE 4 0.0144
55 CORNEAL SCAR 7 0.0139
56 OPHTHALMIC HERPES SIMPLEX 8 0.0139
57 ENDOCRINE OPHTHALMOPATHY 12 0.0138
58 CELLULITIS ORBITAL 8 0.0137
59 CONJUNCTIVAL OEDEMA 14 0.0136
60 CONJUNCTIVAL DISORDER 5 0.0131
61 ENDOPHTHALMITIS 78 0.0130
62 CORNEAL LESION 4 0.0130
63 ULCERATIVE KERATITIS 35 0.0128
64 CHOROIDAL DETACHMENT 7 0.0126
65 EYE INFECTION BACTERIAL 7 0.0125
66 KERATITIS 37 0.0122
67 CORNEAL DEPOSITS 9 0.0121
68 INTRAOCULAR PRESSURE DECREASED 6 0.0114
69 BACTERIAL ENDOPHTHALMITIS 3 0.0113
70 RETINOPATHY 40 0.0107
71 EUSTACHIAN TUBE DYSFUNCTION 6 0.0104
72 CERUMEN IMPACTION 9 0.0098
73 INJURY CORNEAL 5 0.0096
74 CELLULITIS STAPHYLOCOCCAL 6 0.0092
75 CATARACT NUCLEAR 6 0.0090
76 ECTROPION 3 0.0089
77 BANKRUPTCY 4 0.0089
78 MEIBOMIAN GLAND DYSFUNCTION 4 0.0088
79 EYE ULCER 5 0.0087
80 CORNEAL DISORDER 19 0.0087
81 DACRYOSTENOSIS ACQUIRED 11 0.0085
82 INTRAOCULAR PRESSURE TEST ABNORMAL 6 0.0085
83 ANTERIOR CHAMBER CELL 6 0.0084
84 EYELID PAIN 17 0.0084
85 VITREOUS OPACITIES 7 0.0083
86 CORNEAL ABRASION 11 0.0080
87 INTRAOCULAR PRESSURE INCREASED 101 0.0079
88 EYE INFECTION FUNGAL 3 0.0078
89 FOREIGN BODY SENSATION IN EYES 49 0.0077
90 EYELID IRRITATION 19 0.0076
91 SCLERITIS 12 0.0075
92 PERIORBITAL CELLULITIS 4 0.0074
93 CYSTOID MACULAR OEDEMA 14 0.0074
94 MACULAR FIBROSIS 5 0.0074
95 BLEPHARITIS 29 0.0072
96 PERIORBITAL PAIN 6 0.0071
97 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 3 0.0067
98 RETINAL VASCULITIS 8 0.0067
99 EYELID DISORDER 15 0.0065
100 LACRIMATION DECREASED 3 0.0063
101 CATARACT OPERATION COMPLICATION 3 0.0059
102 EPISCLERITIS 4 0.0058
103 DISCHARGE 8 0.0058
104 HYPHAEMA 3 0.0057
105 INSTILLATION SITE ERYTHEMA 3 0.0057
106 CORYNEBACTERIUM INFECTION 3 0.0056
107 FIBROCYSTIC BREAST DISEASE 4 0.0054
108 RETINAL OEDEMA 10 0.0052
109 RETINAL DETACHMENT 48 0.0052
110 LACRIMAL DISORDER 3 0.0052
111 GRAFT COMPLICATION 3 0.0051
112 HYPOAESTHESIA EYE 3 0.0051
113 PRODUCT DROPPER ISSUE 4 0.0051
114 RETINAL PIGMENTATION 4 0.0051
115 CHOROIDAL EFFUSION 4 0.0050
116 SWELLING OF EYELID 31 0.0049
117 CATARACT SUBCAPSULAR 3 0.0049
118 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 6 0.0048
119 ARTHROPOD STING 8 0.0048
120 HAEMOLYTIC URAEMIC SYNDROME 11 0.0047
121 CONJUNCTIVITIS ALLERGIC 7 0.0047
122 VITREOUS HAEMORRHAGE 13 0.0047
123 ANGLE CLOSURE GLAUCOMA 12 0.0047
124 CHALAZION 3 0.0047
125 HORDEOLUM 20 0.0046
126 ERYTHEMA OF EYELID 25 0.0046
127 OCULAR TOXICITY 5 0.0045
128 EYE ALLERGY 7 0.0045
129 EYE INFECTION 50 0.0044
130 ESSENTIAL HYPERTENSION 8 0.0044
131 EYE PAIN 243 0.0043
132 PHOTOPHOBIA 81 0.0043
133 OPTIC ATROPHY 7 0.0043
134 ECHOCARDIOGRAM ABNORMAL 6 0.0043
135 FOREIGN BODY IN EYE 4 0.0042
136 SEBORRHOEIC KERATOSIS 6 0.0041
137 EYE OEDEMA 10 0.0041
138 CONJUNCTIVITIS 74 0.0040
139 EYE INFLAMMATION 38 0.0040
140 UVEITIS 53 0.0039
141 COAGULATION TEST ABNORMAL 3 0.0039
142 CORNEAL TRANSPLANT 3 0.0038
143 KERATOPATHY 6 0.0038
144 OPTIC NERVE DISORDER 6 0.0037
145 INTERVERTEBRAL DISC SPACE NARROWING 3 0.0037
146 CONJUNCTIVAL HAEMORRHAGE 14 0.0037
147 SUPERFICIAL INJURY OF EYE 4 0.0037
148 OCULAR HYPERAEMIA 170 0.0036
149 OPTIC NERVE INJURY 4 0.0034
150 PERSONALITY DISORDER 9 0.0034
151 RESTRICTIVE PULMONARY DISEASE 4 0.0034
152 MACULAR OEDEMA 19 0.0034
153 DEAFNESS NEUROSENSORY 11 0.0033
154 HYPERPLASIA 3 0.0033
155 OCULAR DISCOMFORT 37 0.0033
156 DYSCHEZIA 10 0.0033
157 EYE DISCHARGE 34 0.0033
158 COLOUR BLINDNESS 3 0.0033
159 RENAL ATROPHY 4 0.0032
160 HYPERPARATHYROIDISM SECONDARY 8 0.0032
161 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
162 MACULAR HOLE 4 0.0030
163 EYE IRRITATION 169 0.0029
164 CARBON DIOXIDE INCREASED 4 0.0029
165 EYELIDS PRURITUS 9 0.0029
166 LACRIMATION INCREASED 86 0.0028
167 KYPHOSIS 5 0.0028
168 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
169 INSTILLATION SITE PAIN 7 0.0028
170 NEPHROGENIC ANAEMIA 13 0.0028
171 ABNORMAL SENSATION IN EYE 12 0.0028
172 OPHTHALMIC HERPES ZOSTER 5 0.0028
173 GLAUCOMA 53 0.0027
174 AORTIC ARTERIOSCLEROSIS 7 0.0027
175 METAMORPHOPSIA 5 0.0027
176 EXCESSIVE EYE BLINKING 4 0.0027
177 EYE INJURY 8 0.0026
178 ASTHENOPIA 14 0.0025
179 INSTILLATION SITE IRRITATION 3 0.0025
180 EYE SWELLING 92 0.0025
181 COLONIC POLYP 4 0.0024
182 EYELID MARGIN CRUSTING 7 0.0024
183 HELICOBACTER GASTRITIS 3 0.0024
184 VARICELLA ZOSTER VIRUS INFECTION 5 0.0024
185 EXOPHTHALMOS 5 0.0023
186 ACUTE SINUSITIS 4 0.0023
187 VITREOUS DETACHMENT 5 0.0023
188 PHYSICAL DISABILITY 10 0.0023
189 VISUAL ACUITY REDUCED 75 0.0023
190 OSTEOPENIA 34 0.0022
191 EYELID OEDEMA 24 0.0021
192 NASAL SEPTUM DEVIATION 4 0.0020
193 CONCOMITANT DISEASE PROGRESSION 4 0.0020
194 ECONOMIC PROBLEM 31 0.0020
195 STRABISMUS 6 0.0020
196 RETINAL TEAR 5 0.0020
197 PAPILLOEDEMA 9 0.0020
198 REBOUND ACID HYPERSECRETION 6 0.0020
199 EYELID PTOSIS 20 0.0020
200 FIBROSIS 6 0.0019
201 EYE PRURITUS 64 0.0019
202 IRIDOCYCLITIS 6 0.0019
203 OPTIC NEUROPATHY 4 0.0019
204 CHRONIC SINUSITIS 7 0.0019
205 PEPTIC ULCER 6 0.0018
206 NEPHRITIS 6 0.0018
207 CHOLESTATIC LIVER INJURY 4 0.0018
208 ENTEROBACTER INFECTION 3 0.0018
209 EAR DISCOMFORT 18 0.0018
210 PRODUCT COLOUR ISSUE 9 0.0018
211 BLOOD CHLORIDE INCREASED 3 0.0017
212 EYE DISORDER 57 0.0017
213 PERIORBITAL OEDEMA 9 0.0017
214 ROSACEA 8 0.0017
215 MACULOPATHY 6 0.0017
216 MYOPIA 4 0.0017
217 BLINDNESS UNILATERAL 23 0.0016
218 INFUSION SITE EXTRAVASATION 10 0.0016
219 PERIORBITAL SWELLING 9 0.0016
220 BILE DUCT OBSTRUCTION 3 0.0016
221 DYSLIPIDAEMIA 8 0.0016
222 TONGUE OEDEMA 6 0.0016
223 ADRENAL DISORDER 3 0.0016
224 CATARACT 92 0.0015
225 RETINAL DISORDER 4 0.0015
226 VITREOUS FLOATERS 15 0.0015
227 EYE OPERATION 7 0.0015
228 DIPLEGIA 3 0.0015
229 HYPERLIPIDAEMIA 18 0.0015
230 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
231 TOXIC SKIN ERUPTION 15 0.0015
232 METASTASES TO SPINE 5 0.0015
233 DRY EYE 74 0.0015
234 EAR HAEMORRHAGE 3 0.0015
235 SPINAL OSTEOARTHRITIS 13 0.0015
236 EAR CONGESTION 4 0.0015
237 ORAL FUNGAL INFECTION 4 0.0015
238 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
239 EYE CONTUSION 3 0.0014
240 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
241 LUNG CANCER METASTATIC 4 0.0014
242 HYPERTONIC BLADDER 4 0.0014
243 MADAROSIS 16 0.0014
244 LUMBAR SPINAL STENOSIS 4 0.0014
245 NECK INJURY 4 0.0014
246 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
247 PERIPHERAL VASCULAR DISORDER 7 0.0014
248 BACTERIAL TEST POSITIVE 3 0.0013
249 VISION BLURRED 182 0.0013
250 FACE INJURY 5 0.0013
251 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
252 DIASTOLIC DYSFUNCTION 4 0.0013
253 BLOOD CREATININE DECREASED 4 0.0013
254 RETINAL HAEMORRHAGE 9 0.0013
255 IMPAIRED QUALITY OF LIFE 18 0.0013
256 AZOTAEMIA 5 0.0013
257 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
258 FACET JOINT SYNDROME 4 0.0012
259 EJECTION FRACTION DECREASED 19 0.0012
260 PRODUCT USE COMPLAINT 19 0.0012
261 SEASONAL ALLERGY 17 0.0012
262 EYE HAEMORRHAGE 16 0.0012
263 TINNITUS 55 0.0012
264 ENDODONTIC PROCEDURE 3 0.0012
265 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
266 TOOTH ABSCESS 12 0.0012
267 HEPATIC CYST 4 0.0012
268 DIABETIC RETINOPATHY 4 0.0012
269 FEBRILE BONE MARROW APLASIA 5 0.0012
270 ARTERIOSCLEROSIS 11 0.0012
271 BLOOD CHLORIDE DECREASED 3 0.0012
272 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
273 ACTINIC KERATOSIS 3 0.0012
274 END STAGE RENAL DISEASE 21 0.0012
275 MITRAL VALVE INCOMPETENCE 13 0.0011
276 CAROTID ARTERY STENOSIS 4 0.0011
277 MELANOCYTIC NAEVUS 5 0.0011
278 PIGMENTATION DISORDER 7 0.0011
279 RENAL CYST 9 0.0011
280 CYST 14 0.0011
281 RHINITIS ALLERGIC 5 0.0011
282 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
283 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
284 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
285 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
286 SPINAL COLUMN STENOSIS 5 0.0011
287 CHRONIC KIDNEY DISEASE 80 0.0011
288 COLITIS ISCHAEMIC 7 0.0010
289 TENDONITIS 16 0.0010
290 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
291 RALES 6 0.0010
292 BILIARY COLIC 3 0.0010
293 CREPITATIONS 3 0.0010
294 TRICUSPID VALVE INCOMPETENCE 8 0.0010
295 CEREBRAL ATROPHY 4 0.0010
296 SYMPTOM RECURRENCE 6 0.0010
297 CORONARY ARTERY STENOSIS 5 0.0010
298 IRITIS 3 0.0010
299 DIVERTICULUM 7 0.0010
300 VISUAL IMPAIRMENT 122 0.0010
301 GOITRE 4 0.0010
302 VISUAL FIELD DEFECT 7 0.0010
303 SCOLIOSIS 6 0.0010
304 FAILURE TO THRIVE 5 0.0010
305 BLINDNESS 39 0.0010
306 ORAL DISORDER 7 0.0010
307 MULTIPLE INJURIES 6 0.0010
308 BUNDLE BRANCH BLOCK LEFT 4 0.0009
309 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
310 POST PROCEDURAL COMPLICATION 18 0.0009
311 PURULENT DISCHARGE 4 0.0009
312 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
313 MUSCLE STRAIN 8 0.0009
314 ANGINA UNSTABLE 6 0.0009
315 HAEMORRHOIDS 18 0.0009
316 HYPERKERATOSIS 5 0.0009
317 LUNG INFILTRATION 8 0.0009
318 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
319 SKIN MASS 6 0.0009
320 TEMPERATURE INTOLERANCE 9 0.0009
321 VENTRICULAR EXTRASYSTOLES 9 0.0009
322 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
323 PRESYNCOPE 21 0.0009
324 DISABILITY 17 0.0009
325 EAR PRURITUS 3 0.0009
326 SKIN TIGHTNESS 4 0.0008
327 VAGINAL INFECTION 4 0.0008
328 DIPLOPIA 22 0.0008
329 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
330 GLOSSITIS 3 0.0008
331 CATARACT OPERATION 5 0.0008
332 ANHEDONIA 22 0.0008
333 INFLAMMATION 43 0.0008
334 BONE LESION 3 0.0008
335 DERMATITIS BULLOUS 6 0.0008
336 BURSITIS 10 0.0008
337 STAPHYLOCOCCAL INFECTION 27 0.0008
338 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
339 CARDIAC MURMUR 7 0.0008
340 DIABETIC NEUROPATHY 4 0.0008
341 PRE-EXISTING CONDITION IMPROVED 5 0.0008
342 SECRETION DISCHARGE 10 0.0008
343 VULVOVAGINAL PRURITUS 4 0.0008
344 SLEEP APNOEA SYNDROME 15 0.0008
345 FACIAL PAIN 7 0.0008
346 PHLEBITIS 4 0.0008
347 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
348 EAR PAIN 15 0.0008
349 RASH MACULO-PAPULAR 17 0.0008
350 IMMUNE SYSTEM DISORDER 10 0.0008
351 MACULAR DEGENERATION 9 0.0008
352 BACTERIAL INFECTION 14 0.0007
353 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
354 FRUSTRATION TOLERANCE DECREASED 6 0.0007
355 PRODUCT RESIDUE PRESENT 4 0.0007
356 GINGIVITIS 4 0.0007
357 HYPERURICAEMIA 3 0.0007
358 ANAPHYLACTOID REACTION 3 0.0007
359 PHOTOSENSITIVITY REACTION 12 0.0007
360 DEAFNESS UNILATERAL 4 0.0007
361 ENCEPHALITIS 5 0.0007
362 LARGE INTESTINE POLYP 5 0.0007
363 CONGESTIVE CARDIOMYOPATHY 3 0.0007
364 HYPOMAGNESAEMIA 10 0.0007
365 VITAMIN D DEFICIENCY 7 0.0007
366 PELVIC PAIN 13 0.0007
367 EAR INFECTION 19 0.0007
368 ACUTE PULMONARY OEDEMA 4 0.0007
369 LIGAMENT SPRAIN 7 0.0007
370 PERONEAL NERVE PALSY 4 0.0007
371 IMPAIRED DRIVING ABILITY 8 0.0007
372 DERMATITIS CONTACT 8 0.0007
373 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
374 PSYCHOLOGICAL TRAUMA 6 0.0007
375 EMPHYSEMA 7 0.0007
376 CHAPPED LIPS 3 0.0007
377 DIVERTICULUM INTESTINAL 3 0.0007
378 GINGIVAL SWELLING 3 0.0007
379 BLINDNESS TRANSIENT 5 0.0007
380 PSYCHIATRIC SYMPTOM 5 0.0007
381 CATHETERISATION CARDIAC 3 0.0007
382 WRONG DRUG ADMINISTERED 6 0.0007
383 OSTEOMYELITIS 12 0.0007
384 CORONARY ARTERY DISEASE 20 0.0007
385 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
386 LUMBAR VERTEBRAL FRACTURE 3 0.0007
387 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
388 FACE OEDEMA 11 0.0007
389 RENAL FAILURE CHRONIC 5 0.0006
390 LOCALISED OEDEMA 3 0.0006
391 GENERALISED OEDEMA 8 0.0006
392 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
393 GASTRITIS EROSIVE 3 0.0006
394 ERYTHEMA MULTIFORME 6 0.0006
395 PRODUCT ADMINISTRATION ERROR 13 0.0006
396 CARPAL TUNNEL SYNDROME 9 0.0006
397 MULTIPLE ALLERGIES 5 0.0006
398 INFUSION SITE SWELLING 4 0.0006
399 BLEPHAROSPASM 4 0.0006
400 MUSCLE ATROPHY 8 0.0006
401 ATRIAL FLUTTER 5 0.0006
402 MYDRIASIS 8 0.0006
403 ROTATOR CUFF SYNDROME 8 0.0006
404 HYPERCHOLESTEROLAEMIA 6 0.0006
405 RHINITIS 5 0.0006
406 CARDIAC FLUTTER 4 0.0006
407 HIATUS HERNIA 8 0.0006
408 HEPATITIS ACUTE 4 0.0006
409 CARDIOMYOPATHY 9 0.0006
410 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
411 TOOTHACHE 11 0.0006
412 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
413 EXPIRED DRUG ADMINISTERED 3 0.0006
414 SINUS DISORDER 12 0.0006
415 ABDOMINAL TENDERNESS 3 0.0006
416 DERMATITIS EXFOLIATIVE 3 0.0006
417 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
418 INJURY 42 0.0006
419 HYPOAESTHESIA ORAL 9 0.0006
420 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
421 SINUS CONGESTION 8 0.0006
422 PLEURAL EFFUSION 36 0.0006
423 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
424 EYE MOVEMENT DISORDER 4 0.0006
425 CACHEXIA 3 0.0006
426 HAIR GROWTH ABNORMAL 4 0.0006
427 DEAFNESS 15 0.0006
428 PAPULE 4 0.0006
429 PNEUMOTHORAX 9 0.0006
430 SCIATICA 9 0.0006
431 ORAL HERPES 11 0.0006
432 BREAST PAIN 6 0.0006
433 BODY HEIGHT DECREASED 6 0.0006
434 FOOD POISONING 3 0.0006
435 ANAL FISSURE 3 0.0006
436 CHEILITIS 3 0.0006
437 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
438 EXOSTOSIS 5 0.0005
439 INTESTINAL ISCHAEMIA 3 0.0005
440 INCREASED TENDENCY TO BRUISE 5 0.0005
441 INFUSION SITE PAIN 7 0.0005
442 DENTAL CARIES 6 0.0005
443 DEFORMITY 5 0.0005
444 HYDRONEPHROSIS 4 0.0005
445 FLANK PAIN 5 0.0005
446 HYPERSENSITIVITY 98 0.0005
447 SPUTUM DISCOLOURED 5 0.0005
448 GRANULOCYTOPENIA 3 0.0005
449 SCAB 6 0.0005
450 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
451 DRUG DISPENSING ERROR 8 0.0005
452 INSURANCE ISSUE 8 0.0005
453 HERPES VIRUS INFECTION 3 0.0005
454 RENAL FAILURE 69 0.0005
455 OSTEOARTHRITIS 22 0.0005
456 POST PROCEDURAL HAEMORRHAGE 6 0.0005
457 EOSINOPHILIA 9 0.0005
458 DISCOMFORT 31 0.0005
459 BODY TEMPERATURE DECREASED 5 0.0005
460 SWELLING FACE 33 0.0005
461 BLOOD ALBUMIN DECREASED 4 0.0005
462 ANAPHYLACTIC SHOCK 13 0.0005
463 CHOLECYSTITIS 6 0.0005
464 OBESITY 8 0.0005
465 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
466 SKIN REACTION 7 0.0005
467 SENSORY LOSS 4 0.0005
468 RESTLESS LEGS SYNDROME 9 0.0005
469 NOCTURIA 6 0.0005
470 DIALYSIS 7 0.0005
471 INGUINAL HERNIA 3 0.0005
472 NEUTROPHIL COUNT INCREASED 5 0.0005
473 HYPERAESTHESIA 4 0.0005
474 ACUTE CORONARY SYNDROME 4 0.0005
475 PETECHIAE 5 0.0005
476 DERMATITIS 10 0.0005
477 SENSATION OF FOREIGN BODY 4 0.0005
478 URINARY INCONTINENCE 14 0.0005
479 RENAL INJURY 14 0.0005
480 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
481 PRODUCT CONTAINER ISSUE 4 0.0005
482 RECTAL HAEMORRHAGE 20 0.0005
483 MUSCULOSKELETAL DISCOMFORT 8 0.0005
484 HYPOGAMMAGLOBULINAEMIA 3 0.0005
485 ORAL CANDIDIASIS 6 0.0005
486 DERMATITIS ATOPIC 24 0.0005
487 DYSPHAGIA 43 0.0005
488 APPETITE DISORDER 3 0.0005
489 MUSCULOSKELETAL CHEST PAIN 7 0.0005
490 HEAD DISCOMFORT 8 0.0005
491 RESPIRATORY RATE INCREASED 4 0.0005
492 STEVENS-JOHNSON SYNDROME 10 0.0004
493 BASAL CELL CARCINOMA 7 0.0004
494 CHOLECYSTITIS CHRONIC 3 0.0004
495 BLOOD CALCIUM DECREASED 5 0.0004
496 OSTEONECROSIS OF JAW 11 0.0004
497 TASTE DISORDER 9 0.0004
498 RESPIRATORY TRACT CONGESTION 7 0.0004
499 SINUSITIS 45 0.0004
500 OSTEOPOROSIS 18 0.0004
501 RIB FRACTURE 9 0.0004
502 CORONARY ARTERY OCCLUSION 6 0.0004
503 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
504 IRON DEFICIENCY ANAEMIA 4 0.0004
505 MUSCLE TIGHTNESS 7 0.0004
506 EMOTIONAL DISTRESS 52 0.0004
507 HEPATIC STEATOSIS 8 0.0004
508 BLOOD CHOLESTEROL INCREASED 20 0.0004
509 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
510 DUODENAL ULCER 3 0.0004
511 BLOOD IRON DECREASED 5 0.0004
512 CELLULITIS 21 0.0004
513 ACUTE RESPIRATORY FAILURE 8 0.0004
514 CANDIDA INFECTION 7 0.0004
515 EPISTAXIS 31 0.0004
516 ATELECTASIS 4 0.0004
517 ADRENAL INSUFFICIENCY 5 0.0004
518 PALPITATIONS 48 0.0004
519 ENCEPHALOPATHY 10 0.0004
520 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
521 HYPOPHOSPHATAEMIA 3 0.0004
522 HYPERCALCAEMIA 5 0.0004
523 MULTI-ORGAN FAILURE 7 0.0004
524 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
525 HAEMATOCRIT DECREASED 8 0.0004
526 BLADDER DISORDER 4 0.0004
527 ILEUS 5 0.0004
528 SKIN LESION 11 0.0004
529 OVARIAN CYST 4 0.0004
530 PEMPHIGUS 5 0.0004
531 BONE LOSS 6 0.0004
532 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
533 HAEMODYNAMIC INSTABILITY 3 0.0004
534 GALLBLADDER DISORDER 7 0.0004
535 FUNGAL INFECTION 13 0.0004
536 LEUKOCYTOSIS 7 0.0004
537 PULMONARY HYPERTENSION 8 0.0004
538 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
539 TRANSFUSION 4 0.0004
540 ARRHYTHMIA 18 0.0004
541 PRODUCT PRESCRIBING ERROR 9 0.0004
542 GINGIVAL PAIN 3 0.0004
543 DYSGEUSIA 28 0.0004
544 ANXIETY 106 0.0004
545 FIBROMYALGIA 9 0.0004
546 NEURALGIA 9 0.0004
547 FOOT FRACTURE 7 0.0004
548 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
549 LYMPHADENOPATHY 13 0.0004
550 OESOPHAGITIS 4 0.0004
551 WOUND INFECTION 4 0.0004
552 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
553 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
554 RESPIRATORY DISTRESS 10 0.0004
555 VIRAL INFECTION 12 0.0004
556 POLLAKIURIA 15 0.0004
557 ORAL PAIN 8 0.0004
558 INFUSION SITE ERYTHEMA 3 0.0004
559 DYSPEPSIA 35 0.0004
560 HEMIPARESIS 6 0.0004
561 HEART RATE IRREGULAR 8 0.0004
562 REBOUND EFFECT 4 0.0004
563 RENAL FAILURE ACUTE 15 0.0004
564 HEPATOCELLULAR INJURY 5 0.0004
565 BRONCHITIS 26 0.0004
566 BONE DENSITY DECREASED 11 0.0004
567 MICTURITION URGENCY 4 0.0003
568 PARALYSIS 5 0.0003
569 CARDIOGENIC SHOCK 5 0.0003
570 HYPOACUSIS 15 0.0003
571 NIGHTMARE 12 0.0003
572 BLOOD PRESSURE INCREASED 53 0.0003
573 METASTASES TO LUNG 4 0.0003
574 CYSTITIS 11 0.0003
575 ORTHOSTATIC HYPOTENSION 6 0.0003
576 VASCULITIS 4 0.0003
577 HEART RATE INCREASED 34 0.0003
578 GASTROENTERITIS 5 0.0003
579 NIGHT SWEATS 11 0.0003
580 NECK PAIN 19 0.0003
581 CONSTIPATION 74 0.0003
582 DEEP VEIN THROMBOSIS 22 0.0003
583 ABDOMINAL DISTENSION 35 0.0003
584 OROPHARYNGEAL PAIN 31 0.0003
585 MUSCLE SPASMS 61 0.0003
586 GASTROENTERITIS VIRAL 6 0.0003
587 ERYTHEMA 68 0.0003
588 LOCALISED INFECTION 8 0.0003
589 PNEUMONITIS 9 0.0003
590 LIP SWELLING 11 0.0003
591 MENTAL IMPAIRMENT 8 0.0003
592 BONE DISORDER 6 0.0003
593 ACUTE KIDNEY INJURY 50 0.0003
594 NEUROPATHY PERIPHERAL 31 0.0003
595 MUSCULAR WEAKNESS 37 0.0003
596 PHARYNGEAL OEDEMA 5 0.0003
597 HYPOKALAEMIA 15 0.0003
598 ECZEMA 17 0.0003
599 EXTRAPYRAMIDAL DISORDER 8 0.0003
600 HEPATIC ENCEPHALOPATHY 3 0.0003
601 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
602 TARDIVE DYSKINESIA 9 0.0003
603 BLOOD SODIUM DECREASED 6 0.0003
604 FEELING JITTERY 6 0.0003
605 INCREASED APPETITE 6 0.0003
606 CHOLESTASIS 6 0.0003
607 LOWER LIMB FRACTURE 6 0.0003
608 AFFECT LABILITY 3 0.0003
609 PRODUCT QUALITY ISSUE 42 0.0003
610 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
611 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
612 HYPERTENSION 65 0.0003
613 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
614 NEPHROLITHIASIS 14 0.0003
615 METASTASES TO BONE 5 0.0003
616 IMPAIRED HEALING 10 0.0003
617 TOOTH INFECTION 4 0.0003
618 PULMONARY CONGESTION 4 0.0003
619 PERICARDIAL EFFUSION 7 0.0003
620 INABILITY TO AFFORD MEDICATION 3 0.0003
621 DRUG LEVEL INCREASED 5 0.0003
622 BLOOD PRESSURE ABNORMAL 6 0.0003
623 BACK PAIN 70 0.0003
624 RENAL DISORDER 14 0.0003
625 SKIN DISORDER 10 0.0003
626 DYSURIA 11 0.0003
627 MENTAL DISORDER 13 0.0003
628 BLOOD UREA INCREASED 5 0.0003
629 JOINT RANGE OF MOTION DECREASED 4 0.0003
630 SLEEP DISORDER 21 0.0003
631 ILL-DEFINED DISORDER 18 0.0003
632 CONDITION AGGRAVATED 90 0.0003
633 PRODUCTIVE COUGH 14 0.0003
634 CHEST DISCOMFORT 30 0.0003
635 GINGIVAL BLEEDING 4 0.0003
636 EMOTIONAL DISORDER 9 0.0003
637 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
638 HYPERBILIRUBINAEMIA 3 0.0003
639 NASAL CONGESTION 17 0.0003
640 RESPIRATORY FAILURE 21 0.0003
641 ARTHROPATHY 16 0.0003
642 ATRIAL FIBRILLATION 28 0.0003
643 URINARY TRACT INFECTION 49 0.0003
644 DIZZINESS 143 0.0003
645 WEIGHT DECREASED 80 0.0003
646 THROMBOCYTOPENIA 32 0.0003
647 HEADACHE 179 0.0003
648 MOUTH ULCERATION 6 0.0003
649 PULMONARY EMBOLISM 27 0.0003
650 INCONTINENCE 3 0.0003
651 JOINT DISLOCATION 3 0.0003
652 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
653 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
654 DRUG ERUPTION 5 0.0003
655 SINUS TACHYCARDIA 4 0.0003
656 BRONCHOSPASM 4 0.0003
657 THIRST 5 0.0003
658 IRRITABLE BOWEL SYNDROME 6 0.0003
659 ARTHRITIS 22 0.0003
660 VERTIGO 17 0.0003
661 DECREASED ACTIVITY 3 0.0003
662 BALANCE DISORDER 24 0.0003
663 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
664 PARAESTHESIA ORAL 4 0.0003
665 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
666 DEPRESSION 63 0.0003
667 HYPERTHYROIDISM 4 0.0003
668 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
669 ASPIRATION 3 0.0003
670 HYPOPHAGIA 7 0.0003
671 BONE PAIN 16 0.0003
672 CHILLS 32 0.0003
673 GAIT DISTURBANCE 52 0.0003
674 ACUTE MYOCARDIAL INFARCTION 8 0.0003
675 CHEST PAIN 50 0.0003
676 MALNUTRITION 3 0.0003
677 BLISTER 15 0.0003
678 FRACTURE 5 0.0003
679 CARDIAC FAILURE CONGESTIVE 21 0.0003
680 MUSCLE TWITCHING 6 0.0003
681 SEPSIS 29 0.0003
682 ALOPECIA 51 0.0003
683 PERIPHERAL SWELLING 40 0.0003
684 AGITATION 19 0.0003
685 HERNIA 5 0.0003
686 OFF LABEL USE 226 0.0003
687 DELUSION 4 0.0003
688 RASH MACULAR 9 0.0003
689 PNEUMONIA 83 0.0003
690 PLASMA CELL MYELOMA 10 0.0003
691 HEART RATE DECREASED 9 0.0003
692 SWOLLEN TONGUE 8 0.0003
693 FLUID RETENTION 13 0.0003
694 CYANOSIS 4 0.0003
695 INFLUENZA 28 0.0003
696 COVID-19 44 0.0003
697 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
698 HYPOTHYROIDISM 8 0.0003
699 ABDOMINAL DISCOMFORT 42 0.0003
700 DIABETIC KETOACIDOSIS 6 0.0002
701 CARDIAC FAILURE 20 0.0002
702 ANGIOEDEMA 11 0.0002
703 FULL BLOOD COUNT DECREASED 5 0.0002
704 PAIN IN JAW 7 0.0002
705 HYPERGLYCAEMIA 9 0.0002
706 BLOOD POTASSIUM INCREASED 4 0.0002
707 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
708 BLOOD CREATININE INCREASED 16 0.0002
709 ANGINA PECTORIS 7 0.0002
710 CARDIOMEGALY 3 0.0002
711 OSTEONECROSIS 8 0.0002
712 MULTIPLE FRACTURES 4 0.0002
713 VENTRICULAR TACHYCARDIA 4 0.0002
714 INFECTION 35 0.0002
715 ANAEMIA 46 0.0002
716 LIVER FUNCTION TEST ABNORMAL 7 0.0002
717 EXPIRED PRODUCT ADMINISTERED 8 0.0002
718 JOINT SWELLING 29 0.0002
719 DEHYDRATION 32 0.0002
720 PYREXIA 83 0.0002
721 SYNCOPE 24 0.0002
722 COUGH 67 0.0002
723 RASH 104 0.0002
724 FALL 79 0.0002
725 DISEASE PROGRESSION 28 0.0002
726 CEREBROVASCULAR ACCIDENT 40 0.0002
727 WHEEZING 14 0.0002
728 CIRCULATORY COLLAPSE 4 0.0002
729 IMPAIRED WORK ABILITY 5 0.0002
730 SCAR 4 0.0002
731 HAEMATURIA 8 0.0002
732 ILLNESS 24 0.0002
733 AMNESIA 15 0.0002
734 RESPIRATORY TRACT INFECTION 6 0.0002
735 RASH ERYTHEMATOUS 11 0.0002
736 ASTHMA 26 0.0002
737 OEDEMA PERIPHERAL 28 0.0002
738 PRODUCT DISPENSING ERROR 5 0.0002
739 LOCAL SWELLING 4 0.0002
740 HYPERKALAEMIA 8 0.0002
741 GASTRITIS 6 0.0002
742 DRUG INTOLERANCE 22 0.0002
743 INTERSTITIAL LUNG DISEASE 11 0.0002
744 BRADYCARDIA 12 0.0002
745 HERPES ZOSTER 13 0.0002
746 FEMUR FRACTURE 7 0.0002
747 TOOTH DISORDER 5 0.0002
748 HAIR TEXTURE ABNORMAL 3 0.0002
749 HAEMOGLOBIN DECREASED 23 0.0002
750 ASTHENIA 84 0.0002
751 PAIN 137 0.0002
752 THROAT IRRITATION 10 0.0002
753 ADVERSE DRUG REACTION 20 0.0002
754 DYSPHONIA 13 0.0002
755 PSORIATIC ARTHROPATHY 9 0.0002
756 LIMB INJURY 6 0.0002
757 IMPAIRED GASTRIC EMPTYING 3 0.0002
758 CONTUSION 21 0.0002
759 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
760 PRODUCT DOSE OMISSION ISSUE 64 0.0002
761 SKIN DISCOLOURATION 10 0.0002
762 HYPERHIDROSIS 28 0.0002
763 PAIN IN EXTREMITY 64 0.0002
764 RHINORRHOEA 14 0.0002
765 DIVERTICULITIS 6 0.0002
766 PLATELET COUNT DECREASED 23 0.0002
767 HAEMOPTYSIS 6 0.0002
768 COORDINATION ABNORMAL 3 0.0002
769 WOUND 6 0.0002
770 DYSPNOEA 121 0.0002
771 OXYGEN SATURATION DECREASED 12 0.0002
772 CHOLELITHIASIS 7 0.0002
773 DYSARTHRIA 8 0.0002
774 DYSPNOEA EXERTIONAL 8 0.0002
775 NAUSEA 168 0.0002
776 FATIGUE 165 0.0002
777 DECREASED APPETITE 49 0.0002
778 GAIT INABILITY 7 0.0002
779 DIARRHOEA 135 0.0002
780 BLOOD PRESSURE FLUCTUATION 5 0.0002
781 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
782 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
783 ERUCTATION 4 0.0002
784 NEUTROPENIA 28 0.0002
785 SKIN FISSURES 4 0.0002
786 HYPOTENSION 41 0.0002
787 ABDOMINAL PAIN UPPER 42 0.0002
788 LABORATORY TEST ABNORMAL 6 0.0002
789 OEDEMA 11 0.0002
790 PRODUCT USE ISSUE 38 0.0002
791 UPPER LIMB FRACTURE 4 0.0002
792 HAEMORRHAGE INTRACRANIAL 3 0.0002
793 MYOCARDIAL INFARCTION 35 0.0002
794 HYPOAESTHESIA 30 0.0002
795 LEUKOPENIA 10 0.0002
796 CYTOKINE RELEASE SYNDROME 4 0.0002
797 TREMOR 33 0.0002
798 HYPOXIA 7 0.0002
799 BLOOD COUNT ABNORMAL 3 0.0002
800 ABDOMINAL PAIN 46 0.0002
801 HAEMATEMESIS 5 0.0002
802 DEVICE FAILURE 3 0.0002
803 FEBRILE NEUTROPENIA 13 0.0002
804 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
805 ANKLE FRACTURE 3 0.0002
806 SKIN ULCER 5 0.0002
807 TREATMENT FAILURE 16 0.0002
808 RASH GENERALISED 5 0.0002
809 TOOTH LOSS 4 0.0002
810 COGNITIVE DISORDER 9 0.0002
811 ACCIDENTAL OVERDOSE 7 0.0002
812 RESTLESSNESS 7 0.0002
813 ROAD TRAFFIC ACCIDENT 8 0.0002
814 SEIZURE 22 0.0002
815 RENAL IMPAIRMENT 16 0.0002
816 SKIN EXFOLIATION 16 0.0002
817 HEAD INJURY 6 0.0002
818 HALLUCINATION, VISUAL 4 0.0002
819 DISEASE RECURRENCE 9 0.0002
820 INSOMNIA 50 0.0002
821 RETCHING 4 0.0002
822 PRURITUS 72 0.0002
823 MOVEMENT DISORDER 6 0.0002
824 FEAR 5 0.0002
825 POOR QUALITY SLEEP 4 0.0002
826 SKIN CANCER 4 0.0002
827 INTESTINAL OBSTRUCTION 7 0.0002
828 PAIN OF SKIN 5 0.0002
829 CONFUSIONAL STATE 30 0.0002
830 NASOPHARYNGITIS 34 0.0002
831 SEPTIC SHOCK 8 0.0002
832 LUNG DISORDER 9 0.0002
833 PRODUCT STORAGE ERROR 16 0.0002
834 MUSCULOSKELETAL STIFFNESS 16 0.0002
835 INFLUENZA LIKE ILLNESS 15 0.0002
836 APPLICATION SITE PAIN 4 0.0002
837 CYTOMEGALOVIRUS INFECTION 3 0.0002
838 PROCEDURAL PAIN 5 0.0002
839 COAGULOPATHY 3 0.0002
840 MENTAL STATUS CHANGES 5 0.0002
841 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
842 GLOSSODYNIA 4 0.0002
843 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
844 PARAESTHESIA 28 0.0002
845 THERAPY NON-RESPONDER 8 0.0002
846 ANGER 6 0.0002
847 INTENTIONAL DOSE OMISSION 5 0.0002
848 RED BLOOD CELL COUNT DECREASED 5 0.0002
849 SKIN IRRITATION 8 0.0002
850 LETHARGY 10 0.0002
851 DRY MOUTH 14 0.0002
852 HOT FLUSH 13 0.0002
853 DYSKINESIA 7 0.0002
854 MUSCULOSKELETAL PAIN 9 0.0002
855 NEUTROPHIL COUNT DECREASED 7 0.0002
856 MYALGIA 29 0.0002
857 COLD SWEAT 3 0.0002
858 ASCITES 5 0.0002
859 LYMPHOCYTE COUNT DECREASED 3 0.0002
860 TACHYCARDIA 15 0.0002
861 THERAPY INTERRUPTED 12 0.0002
862 MEMORY IMPAIRMENT 23 0.0002
863 GOUT 3 0.0002
864 RESPIRATORY DISORDER 5 0.0002
865 MOBILITY DECREASED 12 0.0002
866 BLOOD POTASSIUM DECREASED 5 0.0002
867 RASH PRURITIC 9 0.0002
868 SUICIDAL IDEATION 15 0.0002
869 ADVERSE EVENT 15 0.0002
870 AGRANULOCYTOSIS 3 0.0002
871 PANCYTOPENIA 9 0.0002
872 SWELLING 15 0.0002
873 INTENTIONAL PRODUCT MISUSE 14 0.0002
874 HYPONATRAEMIA 9 0.0002
875 FLATULENCE 9 0.0002
876 FEELING ABNORMAL 38 0.0002
877 VOMITING 74 0.0002
878 MIGRAINE 15 0.0002
879 COLITIS ULCERATIVE 7 0.0002
880 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
881 DRUG PRESCRIBING ERROR 3 0.0002
882 LOSS OF CONSCIOUSNESS 20 0.0002
883 ERECTILE DYSFUNCTION 4 0.0002
884 HIP FRACTURE 5 0.0002
885 DYSTONIA 3 0.0002
886 CHOKING 3 0.0002
887 NERVOUSNESS 8 0.0002
888 ABNORMAL BEHAVIOUR 6 0.0002
889 DRY SKIN 20 0.0001
890 URTICARIA 25 0.0001
891 SOMNOLENCE 30 0.0001
892 FEEDING DISORDER 3 0.0001
893 THROAT TIGHTNESS 4 0.0001
894 BONE MARROW FAILURE 3 0.0001
895 TREATMENT NONCOMPLIANCE 8 0.0001
896 GASTRIC DISORDER 5 0.0001
897 UNEVALUABLE EVENT 11 0.0001
898 ABNORMAL DREAMS 4 0.0001
899 DIABETES MELLITUS 11 0.0001
900 FEELING COLD 4 0.0001
901 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
902 DEMENTIA 4 0.0001
903 KNEE ARTHROPLASTY 3 0.0001
904 ARTHRALGIA 59 0.0001
905 MALAISE 62 0.0001
906 EATING DISORDER 3 0.0001
907 JOINT INJURY 3 0.0001
908 LIVER FUNCTION TEST INCREASED 3 0.0001
909 DRUG INEFFECTIVE 184 0.0001
910 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
911 FAECES DISCOLOURED 3 0.0001
912 DEVICE DISLOCATION 6 0.0001
913 PANIC ATTACK 5 0.0001
914 DYSSTASIA 4 0.0001
915 THROMBOSIS 11 0.0001
916 SURGERY 8 0.0001
917 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
918 INFUSION RELATED REACTION 9 0.0001
919 NEOPLASM MALIGNANT 9 0.0001
920 IRRITABILITY 8 0.0001
921 BLOOD GLUCOSE INCREASED 25 0.0001
922 HEPATIC FAILURE 4 0.0001
923 FEELING HOT 8 0.0001
924 WEIGHT INCREASED 29 0.0001
925 LIMB DISCOMFORT 4 0.0001
926 BURNING SENSATION 9 0.0001
927 HAEMATOCHEZIA 7 0.0001
928 DISORIENTATION 5 0.0001
929 DRUG INTERACTION 20 0.0001
930 HYPOGLYCAEMIA 6 0.0001
931 CEREBRAL INFARCTION 3 0.0001
932 CONVULSION 7 0.0001
933 AGEUSIA 3 0.0001
934 ACNE 9 0.0001
935 INJECTION SITE SWELLING 9 0.0001
936 THERAPEUTIC RESPONSE DECREASED 7 0.0001
937 STOMATITIS 7 0.0001
938 PSORIASIS 15 0.0001
939 SPEECH DISORDER 6 0.0001
940 JOINT STIFFNESS 3 0.0001
941 DEPRESSED MOOD 6 0.0001
942 PULMONARY OEDEMA 5 0.0001
943 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
944 GASTROINTESTINAL DISORDER 10 0.0001
945 DISTURBANCE IN ATTENTION 6 0.0001
946 BLOOD BILIRUBIN INCREASED 3 0.0001
947 DRUG EFFECT INCOMPLETE 4 0.0001
948 CRYING 4 0.0001
949 C-REACTIVE PROTEIN INCREASED 4 0.0001
950 CARDIAC ARREST 9 0.0001
951 FLUSHING 11 0.0001
952 MEDICATION ERROR 6 0.0001
953 PRODUCT DOSE OMISSION 7 0.0001
954 TOXICITY TO VARIOUS AGENTS 18 0.0001
955 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
956 HYPERSOMNIA 3 0.0001
957 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
958 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
960 SKIN BURNING SENSATION 7 0.0001
961 CARDIAC DISORDER 9 0.0001
962 CARDIO-RESPIRATORY ARREST 4 0.0001
963 DRUG-INDUCED LIVER INJURY 3 0.0001
964 INCORRECT DOSE ADMINISTERED 21 0.0001
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
966 DRUG DOSE OMISSION 15 0.0001
967 BLOOD PRESSURE DECREASED 6 0.0001
968 RHEUMATOID ARTHRITIS 10 0.0001
969 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
970 INJECTION SITE HAEMORRHAGE 7 0.0001
971 DELIRIUM 3 0.0001
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
973 CEREBRAL HAEMORRHAGE 3 0.0001
974 UNDERDOSE 6 0.0001
975 EXPOSURE DURING PREGNANCY 5 0.0001
976 HEPATIC FUNCTION ABNORMAL 3 0.0001
977 HALLUCINATION 6 0.0001
978 HAEMORRHAGE 8 0.0001
979 PANCREATITIS 4 0.0001
980 INJECTION SITE BRUISING 6 0.0001
981 INJECTION SITE PRURITUS 5 0.0001
982 EXTRA DOSE ADMINISTERED 3 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
984 INJECTION SITE REACTION 5 0.0001
985 ANAPHYLACTIC REACTION 4 0.0001
986 INJECTION SITE PAIN 21 0.0001
987 HOSPITALISATION 10 0.0001
988 BREAST CANCER 6 0.0001
989 DEATH 53 0.0001
990 DEVICE MALFUNCTION 4 0.0001
991 DRUG DEPENDENCE 8 0.0000
992 NO ADVERSE EVENT 9 0.0000
993 HEPATIC ENZYME INCREASED 3 0.0000
994 OVERDOSE 6 0.0000